Advanced Rare Tumours
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Durvalumab and Tremelimumab in Patients With Advanced Rare Tumours (NCT02879162) | Canadian Cancer Trials Group | 2016-12-14 |
| A Phase II Study of Sunitinib or Temsirolimus in Patients With Advanced Rare Tumours (NCT01396408) | Canadian Cancer Trials Group | 2012-02-09 |
Track Advanced Rare Tumours automatically
Every clearance here is in the API, with alerts when new ones post.